Life Science Investing Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Life Science Investing Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
Life Science Investing Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting
